Bone marrow transfer BOOST for heart attack victims:
This article was originally published in Clinica
Injecting a person's own bone marrow cells directly into their heart after angioplasty to treat a heart attack improves heart function, long-term data from a study of the technique have revealed. Previous six-month data from the study, called BOOST, showed that intracoronary transfer of autologous bone marrow cells after angioplasty significantly improved left ventricular ejection fraction (LVEF) - a measure of the heart's pumping ability - compared to a control group. According to MRI analysis after 16 months, LVEF improved by 7.3% in the cell transfer patients, compared to just 2.7% for the controls. The findings were presented by Dr Gerd Meyer and colleagues, of the Medical School, in Hanover, Germany, at this month's American Heart Association meeting in New Orleans.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.